BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND RNF43, DKFZp781H02126, 54894, Q68DV7, URCC, RNF124, MGC125630, FLJ20315, DKFZp781H0392 AND Treatment
13 results:

  • 1. rnf43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in cancer Cells.
    Hsu SH; Tsai YL; Wang YT; Shen CH; Hung YH; Chen LT; Hung WC
    Adv Sci (Weinh); 2024 Mar; 11(12):e2304820. PubMed ID: 38225722
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
    Wang W; Zhang D; Chang D; Li Y; Ren L
    Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate cancer.
    Sutera P; Deek MP; Van der Eecken K; Shetty AC; Chang JH; Hodges T; Song Y; Verbeke S; Van Dorpe J; Fonteyne V; De Laere B; Mishra M; Rana Z; Molitoris J; Ferris M; Ross A; Schaeffer E; Roberts N; Song DY; DeWeese T; Pienta KJ; Antonarakis ES; Ost P; Tran PT
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1095-1101. PubMed ID: 36708787
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted pancreatic cancer.
    Aguilera KY; Le T; Riahi R; Lay AR; Hinz S; Saadat EA; Vashisht AA; Wohlschlegel J; Donahue TR; Radu CG; Dawson DW
    Mol Cancer Ther; 2022 Jun; 21(6):936-947. PubMed ID: 35313331
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Loss of rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in pancreatic Adenocarcinoma.
    Hosein AN; Dangol G; Okumura T; Roszik J; Rajapakshe K; Siemann M; Zaid M; Ghosh B; Monberg M; Guerrero PA; Singhi A; Haymaker CL; Clevers H; Abou-Elkacem L; Woermann SM; Maitra A
    Gastroenterology; 2022 Apr; 162(4):1303-1318.e18. PubMed ID: 34973294
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments.
    Feng Y; Jiang Y; Hao F
    J Transl Med; 2021 Aug; 19(1):373. PubMed ID: 34461940
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deep Targeted Sequencing and Its Potential Implication for cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
    Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
    Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Acquired resistance to immunotherapy in MMR-D pancreatic cancer.
    Hu ZI; Hellmann MD; Wolchok JD; Vyas M; Shia J; Stadler ZK; Diaz LA; O'Reilly EM
    J Immunother Cancer; 2018 Nov; 6(1):127. PubMed ID: 30458888
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrated Molecular Characterization of the Lethal Pediatric cancer Pancreatoblastoma.
    Isobe T; Seki M; Yoshida K; Sekiguchi M; Shiozawa Y; Shiraishi Y; Kimura S; Yoshida M; Inoue Y; Yokoyama A; Kakiuchi N; Suzuki H; Kataoka K; Sato Y; Kawai T; Chiba K; Tanaka H; Shimamura T; Kato M; Iguchi A; Hama A; Taguchi T; Akiyama M; Fujimura J; Inoue A; Ito T; Deguchi T; Kiyotani C; Iehara T; Hosoi H; Oka A; Sanada M; Tanaka Y; Hata K; Miyano S; Ogawa S; Takita J
    Cancer Res; 2018 Feb; 78(4):865-876. PubMed ID: 29233928
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
    Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
    J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
    Wu J; Jiao Y; Dal Molin M; Maitra A; de Wilde RF; Wood LD; Eshleman JR; Goggins MG; Wolfgang CL; Canto MI; Schulick RD; Edil BH; Choti MA; Adsay V; Klimstra DS; Offerhaus GJ; Klein AP; Kopelovich L; Carter H; Karchin R; Allen PJ; Schmidt CM; Naito Y; Diaz LA; Kinzler KW; Papadopoulos N; Hruban RH; Vogelstein B
    Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21188-93. PubMed ID: 22158988
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.